Pharmacodynamic properties for inhibition of cAMP- and cGMP elimination by pentoxifylline remain unaltered in vitro during hypothermia
Open Access
- 15 December 2022
- journal article
- research article
- Published by Springer Nature in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
- Vol. 30 (1) , 1-10
Abstract
Background: Rewarming from hypothermia is associated with severe complications, one of which is hypothermia-induced cardiac dysfunction. This condition is characterized by decreased cardiac output accompanied by increased total peripheral resistance. This contributes to mortality rate approaching 40%. Despite this, no pharmacological interventions are recommended for these patients below 30 °C. Raising the intracellular levels of cAMP and/or cGMP, through PDE3- and PDE5-inhibitors respectively, have showed the ability to alleviate hypothermia-induced cardiac dysfunction in vivo. Drugs that raise levels of both cAMP and cGMP could therefore prove beneficial in patients suffering from hypothermia-induced cardiac dysfunction. Methods: The unselective PDE-inhibitor pentoxifylline was investigated to determine its ability to reach the intracellular space, inhibit PDE3 and PDE5 and inhibit cellular efflux of cAMP and cGMP at temperatures 37, 34, 30, 28, 24 and 20 °C. Recombinant human PDE-enzymes and human erythrocytes were used in the experiments. IC50-values were calculated at all temperatures to determine temperature-dependent changes. Results: At 20 °C, the IC50-value for PDE5-mediated enzymatic breakdown of cGMP was significantly increased compared to normothermia (IC50: 39.4 µM ± 10.9 µM vs. 7.70 µM ± 0.265 µM, p-value = 0.011). No other significant changes in IC50-values were observed during hypothermia. Conclusions: This study shows that pentoxifylline has minimal temperature-dependent pharmacodynamic changes, and that it can inhibit elimination of both cAMP and cGMP at low temperatures. This can potentially be effective treatment of hypothermia-induced cardiac dysfunction. Trial registration: Not applicable.Keywords
Funding Information
- UiT - Norges arktiske universitet
- Stiftelsen Norsk Luftambulanse
- Helse Nord RHF ([HNF1337–17])
- UiT The Arctic University of Norway
This publication has 32 references indexed in Scilit:
- MRP4 and CFTR in the regulation of cAMP and β-adrenergic contraction in cardiac myocytesEuropean Journal of Pharmacology, 2012
- Pentoxifylline for intermittent claudication2012
- The physiologic responses to epinephrine during cooling and after rewarming in vivoCritical Care, 2011
- Overview of PDEs and Their RegulationCirculation Research, 2007
- Clinical applications of induced hypothermiaContinuing Education in Anaesthesia Critical Care & Pain, 2006
- Severe Accidental Hypothermia Treated in an ICUChest, 2001
- The Multidrug Resistance Protein 5 Functions as an ATP-dependent Export Pump for Cyclic NucleotidesJournal of Biological Chemistry, 2000
- Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligandsJournal of Theoretical Biology, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961